← Eichor
Study identifier: NCT07208799 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures

Condition: Mandible Fracture · Edema Face · Pain Management  ·  Sponsor: Nishtar Medical University

PhasePhase 2
Planned participants72
Who can joinAll sexes, 18 Years to 40 Years
Healthy volunteersNo

About this study

The rationale of the current research is to address the limitation of existing knowledge as it is not clear which of the two drugs (Dexamethasone or Methylprednisolone) is more effective in reduction of postoperative sequelae in patient with mandibular parasymphysis fracture. This study fills the gap by providing sound evidence on the preferred steroid option to help clinicians have more data to make decisions and improve patients' health. The result of this research will then be added to the evidence-based protocols for the treatment of parasymphysis fractures.

This description comes directly from the study's public registry record.

Talk to the study team

Ammar ali khalid, Bachelor of dental surgery  ·  923129216146  ·  ammaraligoraya@gmail.com

Dr amjad Bari, M.D.S (OMFS)  ·  +92 300 9630196  ·  dramjad.omfs@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Nishtar Institute of Dentistry MultanMultan, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07208799